Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 53, Issue 4, Pages 1698-1700Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01549-08
Keywords
-
Categories
Ask authors/readers for more resources
The in vivo efficacy of piperacillin in combination with the penem inhibitor BLI-489 was determined using acute lethal systemic infections in mice. On the basis of preliminary results with various ratios, a dosing ratio of 8: 1 was found to be optimal for retention of enhanced efficacy. Piperacillin- BLI-489 dosed at an 8: 1 ratio was efficacious against murine infections caused by class A (including extended-spectrum beta-lactamases), class C (AmpC), and class D beta-lactamase-expressing pathogens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available